BCAT-IN-4
BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases[1].
Product Specifications
CAS Number
406190-85-0
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bcat-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC2=C(OC3=C2C=CC=C3)C=C1)NNS(=O)(C4=CC=CC=C4)=O
Molecular Formula
C19H14N2O4S
Molecular Weight
366.39
References & Citations
[1]Hu LY, et al. The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16 (9) :2337-40.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15091183 1 Vial
Lentiviral human LGALS9 shRNA (UAS) - Lentiviral human LGALS9 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
MBS6333444-01 0.2 mL
PHLPP2, CT (PHLPP2, KIAA0931, PHLPPL, PH domain leucine-rich repeat-containing protein phosphatase 2, PH domain leucine-rich repeat-containing protein phosphatase-like) (Biotin)
Sign In for Pricing
View Details MBS6333444-02 5x 0.2 mL
PHLPP2, CT (PHLPP2, KIAA0931, PHLPPL, PH domain leucine-rich repeat-containing protein phosphatase 2, PH domain leucine-rich repeat-containing protein phosphatase-like) (Biotin)
Sign In for Pricing
View Details 